Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data
- 1 February 2016
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 101, 1-12
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Biased signalling and allosteric machines: new vistas and challenges for drug discoveryBritish Journal of Pharmacology, 2012
- A Simple Method for Quantifying Functional Selectivity and Agonist BiasACS Chemical Neuroscience, 2012
- Discovery of β-Arrestin–Biased Dopamine D2Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic EfficacyProceedings of the National Academy of Sciences, 2011
- Analysis of Agonism and Inverse Agonism in Functional Assays with Constitutive Activity: Estimation of Orthosteric Ligand Affinity Constants for Active and Inactive Receptor StatesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Crystal structure of the β2 adrenergic receptor–Gs protein complexNature, 2011
- The structural basis for agonist and partial agonist action on a β1-adrenergic receptorNature, 2011
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- On the nature of partial agonism in the nicotinic receptor superfamilyNature, 2008
- Agonist binding, agonist affinity and agonist efficacy at G protein‐coupled receptorsBritish Journal of Pharmacology, 2008
- Assays for enhanced activity of low efficacy partial agonists at the D2dopamine receptorBritish Journal of Pharmacology, 2006